Bob is a senior management executive with a track record in the medical device sector. Over his career Bob has been involved in the valuation, acquisition and sale of multiple medical devices. Bob has served as Head of Medical Device & Life Sciences Group for Acacia Research Group (NASDAQ) in the role of SVP, where he built the medical device business to $30 million in revenue. Previously he served as global chief IP counsel for Synthes Inc. (SIX) and the Boston Scientific Corporation (NYSE) Endoscopy business, both multi-billion dollar companies, where he managed the medical products acquisition and licensing transactions along with other senior management roles. Bob has a bachelor’s degree in mechanical engineering and an MBA from the University of Massachusetts and a juris doctorate from the New Hampshire School of Law. Additionally he is a registered patent attorney, a named inventor on 13 patents and pending applications in the medical device sector and joint inventor of the X-PLO2R portable oxygen concentrator. Bob joined the Board in August 2016.
A retired Chartered Accountant, Ric has almost three decades on experience on public company Boards, as Chair, Board Committee Chair, Senior Independent Director and Group Finance Director . He joined Belluscura on Admission to AIM in 2021. Ric is a Board Adviser to a number of privately owned engineering & technology businesses.
Paul qualified as a chartered accountant at KPMG, with over twenty years’ postqualification experience, he has served as Chief Financial Officer as well as NonExecutive Director on a number of AIM quoted companies in the media and technology industries. Over this period, he has led successful IPOs, fundraisings and venture capital exits. Paul joined the Board in February 2024.